KRIYA-825

KRIYA-825 · Kriya Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KRIYA-825, covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 1, Phase 2]

See pricing